SFX by Ex Libris Inc.

Title:	Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides
Source:	Nucleic Acids Research [0305-1048] Wang, S yr:2016

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Juliano, R L. "Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides." Journal of drug targeting 21 (2012): 1-43.
description	2.	Juliano, Rudolph L. "Cellular Uptake and Intracellular Trafficking of Antisense and siRNA Oligonucleotides." Bioconjugate chemistry 23.2 (2012): 147-157.
description	3.	Varkouhi, Amir K. "Endosomal escape pathways for delivery of biologicals." Journal of controlled release 151.3 (2010): 220-228.
description	4.	ZERRES, K. "NATURAL-HISTORY IN PROXIMAL SPINAL MUSCULAR-ATROPHY - CLINICAL ANALYSIS OF 445 PATIENTS AND SUGGESTIONS FOR A MODIFICATION OF EXISTING CLASSIFICATIONS." Archives of neurology 52.5 (1995): 518-523.
description	5.	Juliano, R. "Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides." Molecular pharmaceutics 6.3 (2009): 686-695.
description	6.	Nelson, Michelle H H. "Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity." Bioconjugate chemistry 16.4: 959-966.
description	7.	Rossi, John J J. "Strategies for silencing human disease using RNA interference." Nature reviews. Genetics 8.3 (2007): 173-84.
description	8.	Nakase, I. "Endosome-Disruptive Peptides for Improving Cytosolic Delivery of Bioactive Macromolecules." Biopolymers 94.6 (2010): 763-770.
description	9.	Endoh, T. "Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape." Advanced Drug Delivery Reviews 61.9 (2009): 704-709.
description	10.	Liu, W L. "Molecular analysis of the SMN gene mutations in spinal muscular atrophy patients in China." Genetics and molecular research (2013): 3598-3604.
description	11.	Markowitz, Jennifer A. "Spinal muscular atrophy: a clinical and research update." Pediatric neurology 46.1 (2012): 1-12.
description	12.	Roth, Charles M M. "Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides." Biophysical journal 89.4 (2005): 2286-95.
description	13.	WELANDER, L. "Heredofamilial juvenile muscular atrophy simulating muscular dystrophy." A.M.A. archives of neurology and psychiatry 75.5 (1956): 500-509.
description	14.	McMahon, Harvey T. "Mechanisms of endocytosis." Annual Review of Biochemistry 78.1 (2009): 857-902.
description	15.	Bansal, F. "Neuromuscular ventilatory insufficiency: effect of home mechanical ventilator use v oxygen therapy on pneumonia and hospitalization rates." American journal of physical medicine & rehabilitation 77.1 (1998): 8-19.
description	16.	Kamiya, H. "Intracellular trafficking and transgene expression of viral and non-viral gene vectors." Advanced Drug Delivery Reviews 52.3 (2001): 153-164.
description	17.	Russman, Barry S S. "Spinal muscular atrophy: clinical classification and disease heterogeneity." Journal of child neurology 22.8 (2007): 946-51.
description	18.	Pan, Wei-Hua H. "Antisense applications for biological control." Journal of cellular biochemistry 98.1 (2006): 14-35.
description	19.	FATTAL, E. "Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA." Advanced Drug Delivery Reviews 58.11 (2006): 1203-1223.
description	20.	White, Paul J J. "BARRIERS TO SUCCESSFUL DELIVERY OF SHORT INTERFERING RNA AFTER SYSTEMIC ADMINISTRATION." Clinical and experimental pharmacology & physiology 35.11 (2008): 1371-6.